Tri Valley Plastic Surgery gives prospective weight-management patients something useful before a consultation: separate introductory and subsequent monthly prices for semaglutide and tirzepatide. But those figures are medication prices, not a documented all-inclusive budget. A $50 initial consultation, unspecified package terms, financing and surgery-linked promotions make the financial picture more complicated than the headline numbers. The central question is not simply which monthly price is lower, but what each payment purchases and what obligations accompany it.
This review examines the practice’s published materials consulted October 19, 2026. Tri Valley is a plastic surgery and Med Spa business in Dublin, California, with advertised GLP-1 treatment, clinical evaluation and monthly follow-up. Its materials support describing an actual weight-management offering, rather than merely a cosmetic practice discussing these medicines. They do not identify the dispensed products, pharmacy or complete payment and cancellation terms. For an adult considering enrollment, that leaves a useful published starting point—but not yet a complete treatment quote.
At a glance
- Semaglutide pricing
- The initial consultation is $50; medication is $500 for the first month and $600 for each subsequent month.Sources: [6]
- Tirzepatide pricing
- Tirzepatide is advertised at $700 for the first month and $800 for each subsequent month; the page does not settle whether the $50 consultation fee also applies.
- Packages and financing
- Both programs advertise four- and seven-month packages and financing, without published package prices or full financing terms in the reviewed material.
- Care access
- The practice advertises virtual and in-person consultations, monthly appointments and extended-hours medication pickup.
- Surgery promotion
- The advertised semaglutide promotion credits 50% of program expenses toward surgery after reaching the target weight, with a minimum $5,000 surgeon fee and a maximum $3,600 credit.Sources: [4]
Start with the first payment, not the lowest monthly number
The semaglutide page separates the initial consultation from medication: $50 for the consultation, $500 for the first month of medication and $600 for every subsequent month. The $500 figure is therefore introductory, not the stated ongoing price. The material does not establish whether the consultation and medication charges are collected together, whether the consultation fee is credited later or whether additional charges can arise before treatment begins.
Tirzepatide has its own introductory structure: $700 for the first month and $800 for each subsequent month. The program’s general booking page mentions a $50 consultation, but the reviewed tirzepatide pricing passage does not expressly explain its application to that program. Patients should request a written first-payment breakdown rather than assuming the semaglutide consultation arrangement transfers unchanged. Our guide to understanding the first GLP-1 payment explains why that distinction matters.
The pages describe these periods as months. They do not define a recurring debit date, a four-week billing schedule or how an appointment delay affects payment. Nor do they identify a dose, quantity or presentation tied to each advertised price. Those omissions do not erase the published amounts; they mean the amounts should be treated as specific advertised medication prices whose billing mechanics and product details still need confirmation.
| Item | Published amount or offer | Clarification needed |
|---|---|---|
| Semaglutide consultation | $50 initial consultation | Payment timing and any later credit |
| Semaglutide medication | $500 first month; $600 each subsequent month | Product, quantity and included services |
| Tirzepatide medication | $700 first month; $800 each subsequent month | Consultation charge and other separate fees |
| Four- and seven-month packages | Available for both programs | Total price, payment schedule and exit terms |
| Financing | Available; details supplied on request or at consultation | Lender, interest, fees and repayment terms |
A medication price is not yet an all-inclusive care price
Tri Valley describes a semaglutide program tailored to individual health needs and weight-loss goals, with a comprehensive health assessment and monthly provider follow-ups. These are meaningful service commitments in the program description. What the pricing passage does not do is explicitly connect every service to the monthly medication charge. It remains unclear whether follow-up visits, laboratory testing, injection supplies or other necessary services are included or separately billed.
The tirzepatide page likewise promises monthly check-ins after the initial prescription, tracking weight, blood sugar levels and other relevant health indicators. It encourages regular physical activity and a balanced diet alongside medication, but does not describe a separately staffed nutrition service included in the price. Monitoring blood sugar is not, by itself, documentation of a particular laboratory panel or a promise that laboratory charges are covered.
The practical request is an itemized quote with both recurring and conditional charges: medication, appointments, any testing, supplies and additional consultations. Ask whether the amount changes with the dispensed presentation or treatment changes, rather than assuming either that it does or that it stays fixed. The distinction between a program description and a billing promise is explored further in our guide to what a GLP-1 price includes.
Packages and financing need their own written quote
Both medication pages advertise four- and seven-month treatment packages. Neither reviewed passage supplies the package totals, any discount or the payment schedule. A package’s stated duration does not establish a minimum commitment, an upfront collection requirement or the quantity of medication supplied. It also does not establish that unused months can be refunded. The package offer is real, but its financial advantage cannot be evaluated from these materials.
For semaglutide, Tri Valley says financing is available and that details, including a payment calculator, can be provided on request. For tirzepatide, it says financing information can be discussed during the consultation. The reviewed material does not identify a lender, interest rate, financing fees, qualification requirements or repayment schedule. Financing therefore represents a possible payment arrangement, not evidence of a lower treatment price or an established interest-free option.
Before selecting a package, ask for its total price alongside the ordinary monthly arrangement, the dates payments become due and what happens if treatment changes or stops. Separately confirm insurance handling: the reviewed GLP-1 materials do not establish coverage, insurer billing or medication assistance. NIDDK notes that coverage varies by plan. A financing discussion and an insurance determination answer different questions and should not substitute for one another.
Consultation, pickup and follow-up shape the practical cost
The semaglutide process begins with a PA consultation to discuss weight-loss goals and medical history. The practice says Steven Williams oversees that program and that, if the evaluation is favorable, a patient may leave with medication. That is conditional access, not a guaranteed prescription or guaranteed same-day supply. The tirzepatide description separately says the team evaluates health history, goals and lifestyle to determine an appropriate plan.
The booking page says patients receive shots at monthly appointments and also advertises extended-hours medication pickup. Read together with the possibility of leaving the consultation with medication, these passages establish several access options without fully explaining administration responsibilities. They do not specify who administers every injection, the anatomical route, take-home supplies or a dosing schedule. Monthly appointments should not be interpreted as instructions about injection frequency.
Virtual and in-person consultations are advertised; patients requesting a virtual appointment are asked to say so in the booking notes. Virtual availability does not establish treatment access in every state. Nor does pickup establish home delivery: the reviewed material provides no shipping arrangement, transportation fee or delivery timetable. For budgeting, confirm which visits require travel, where medication is collected and whether remote follow-up is available throughout the program.
Identify the medication before comparing its value
Tri Valley explicitly advertises semaglutide and tirzepatide, but the reviewed materials do not identify the manufacturer, brand, presentation or dispensing pharmacy. They also do not settle whether the supplied preparations are compounded. A reference to “Ozempic face” elsewhere in the practice’s material is not confirmation that Ozempic is dispensed. Without product identification, a price comparison with a named branded medicine or another clinic’s formulation remains incomplete.
FDA approval belongs to a specific product, not to the practice providing care. Although Tri Valley’s tirzepatide page uses FDA-approval language, it does not identify the dispensed product. FDA explains that compounded preparations are not FDA approved and do not undergo its premarket review for safety, effectiveness and quality. That distinction alone neither proves clinical inequivalence nor establishes that Tri Valley uses a compounded preparation.
FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. Ask the clinic to identify the exact product, formulation, presentation and dispensing source before paying for medication. Those answers help make price comparisons meaningful. They also clarify who can answer product-handling questions and who bears responsibility if the medication supplied differs from what the patient expected.
Promotions offer conditional credits, not a lower monthly bill
Tri Valley’s surgery-linked semaglutide promotion offers a credit equal to 50% of program expenses after the patient reaches the target weight. The future surgery must carry a surgeon fee of at least $5,000, and the maximum applicable program credit is $3,600. This is a conditional credit toward another service, not a published cash refund or an automatic reduction in the medication bill. The reviewed material does not state an expiration date.
A separate referral promotion offers $200 in credit when a referred patient enrolls in the semaglutide program. The provider says the credit can be used toward treatments or services, excluding skincare and neurotoxin banks, and can be combined with other promotions. Multiple qualifying referrals can accumulate credits. By contrast, the Med Spa’s $100 new-patient offer explicitly excludes weight-loss treatments and neurotoxin banks; it should not be deducted from an expected GLP-1 payment.
The practice also advertises skin-tightening and body-contouring support after weight loss, with customized quotes following a physical assessment and medical review. These services are not documented as included in medication pricing. Their separate candidate criteria—including maintained weight loss, excess skin, good health and nonsmoking—should not be mistaken for GLP-1 enrollment criteria. Evaluate any cosmetic procedure and its cost independently rather than treating a future credit as money already saved.
Renewal and cancellation remain the major contract gaps
A published subsequent-month price does not explain how renewal works. The reviewed materials do not establish automatic billing, cancellation notice deadlines, pauses, refunds or the handling of unused medication. They also do not explain what financial adjustment occurs if a clinician recommends a change. These are missing terms, not proof that cancellation is prohibited or that refunds are available. Our guide to cancellation and refund boundaries separates those questions.
The website terms state that they were last updated January 1, 2026, and describe the site’s materials as general information rather than comprehensive documentation. Their provisions about terminating website access should not be treated as a treatment-cancellation policy. Before authorizing payment, request the actual patient financial agreement and any package-specific conditions. In particular, establish whether ending future appointments also ends future charges and whether financed payments remain due.
The practice identifies its main office at 11820 Dublin Boulevard, with Monday–Friday hours of 8 a.m.–5 p.m. Its Med Spa is at 11828 Dublin Boulevard and lists later Thursday and Friday hours plus Saturday availability. The booking page directs patients who cannot find a suitable appointment to (925) 875-9011. Those contact details provide a route for clarification, but the published office hours do not establish urgent clinical coverage or support-response guarantees.
Judge the quote alongside the care responsibilities
Tri Valley describes itself as a Dublin practice serving the Bay Area and patients from around the world, led by Steven Williams. Its website presents Williams as a board-certified plastic and reconstructive surgeon and diplomate of the American Board of Plastic Surgery. Those are provider-reported credentials, not independent verification in this review. The practice’s broader geographic reach also does not document nationwide virtual prescribing or identify every clinician responsible for weight-management follow-up.
The semaglutide and tirzepatide pages discuss treatment for people without diabetes, but do not supply complete eligibility criteria, required testing or contraindication screening. These statements are invitations to clinical evaluation, not individual approval. NIDDK advises discussing medical conditions, medicines, supplements, allergies and pregnancy plans with a clinician. It also describes follow-up as assessment of tolerance and response, making the scope of continuing care relevant to value—not merely the number of visits.
Before enrollment, bring together the product identity, first payment, subsequent charges, included monitoring, pickup arrangements and exit terms in one written document. Our GLP-1 quote checklist can help organize that conversation. The final comparison should be between documented care arrangements, not between isolated dollar figures. A higher price does not establish better outcomes, and cosmetic-treatment testimonials do not demonstrate results for this practice’s weight-management program.
Questions & answers
What does Tri Valley publish for the first semaglutide month?
It lists a $50 initial consultation and $500 for the first month of medication, followed by $600 for each subsequent month. The materials do not settle collection timing or every possible additional charge. Ask for a first-payment statement that distinguishes the consultation, medication and any testing or supplies rather than assuming the introductory medication price is the entire enrollment cost.
Does tirzepatide stay at $700 per month?
No. The advertised $700 price applies to the first month; each subsequent month is listed at $800. The tirzepatide pricing passage does not clearly establish whether the general $50 consultation fee applies or what services are included. It also does not identify a product presentation or quantity tied to the monthly amount, so confirm those details before comparing quotes.
Are the four- and seven-month packages prepaid commitments?
The reviewed pages do not say. They advertise both package durations for semaglutide and tirzepatide, but do not publish prices, required prepayment or minimum-commitment terms. Financing is also advertised without full repayment details. Request a package agreement showing the payment schedule, medication provision and what happens financially if treatment is changed, interrupted or discontinued.
Can I use a virtual consultation and have medication shipped?
Virtual consultations are advertised, and the booking page asks patients to request that format in the notes. The materials also advertise local medication pickup. They do not document home shipping or establish access outside California. Confirm your location’s eligibility and collection requirements directly. If an injectable GLP-1 is shipped and arrives warm or insufficiently refrigerated, FDA advises not using it and contacting the provider or pharmacy.
Does the surgery promotion refund half my semaglutide spending?
It is described as a credit toward surgery, not a cash refund. The advertised conditions include reaching the target weight, a minimum surgeon fee of $5,000 and a maximum credit of $3,600, calculated as 50% of program expenses. Ask which expenses qualify and obtain the full current conditions before counting the credit toward a future procedure’s cost.
Who should I contact about appointments or website accessibility?
The booking page lists (925) 875-9011 for patients who cannot find an appointment that works. For accommodations related to using the website, it separately lists an accessibility manager at (925) 875-0700. Neither listing establishes a dedicated urgent-care line or a promised response time for medication concerns. Ask during enrollment which clinical contact to use between scheduled monthly visits.
Our assessment
Tri Valley Plastic Surgery publishes useful introductory and subsequent medication prices and describes a recognizable local care process: evaluation, possible medication access, pickup options and monthly follow-up. Those details make it more financially transparent than an offering with no prices at all. However, the reviewed materials stop short of an all-inclusive quote or complete financial agreement. Product and pharmacy identity, included services, package totals, financing conditions and cancellation rules remain essential unresolved questions. The surgery and referral promotions may have value for qualifying patients, but they are conditional credits rather than straightforward reductions in monthly treatment costs. The sensible next step is a written, itemized quote and patient agreement—not an assumption that the advertised monthly medication charge represents the full cost of care.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- NIDDK: prescription medications for overweight and obesity ↗
- Tri Valley Plastic Surgery — get started with weight loss ↗
- Tri Valley Plastic Surgery — weight loss shots/post weight loss ↗
- Tri Valley Plastic Surgery — about/about tri valley plastic surgery ↗
- Tri Valley Plastic Surgery — weight loss shots/semaglutide ↗
- Tri Valley Plastic Surgery — weight loss shots/tirzepatide ↗
- Tri Valley Plastic Surgery — weight loss shots/ozempic face ↗
- Tri Valley Plastic Surgery — official website ↗
- Tri Valley Plastic Surgery — terms and conditions ↗